Trademarkia Logo

United Kingdom

£
Registered

on 18 Mar 2022

Last Applicant/ Owned by

Myrobalan Therapeutics Holding, Inc.

1337 Massachusetts Avenue, #282, Arlington

, MASSACHUSETTS, 02476

Serial Number

UK00003767421 filed on 18th Mar 2022

Registration Number

UK00003767421 registered on
22nd Sept 2023

Correspondent Information

Keltie LLP

No.1 London Bridge

London,

SE1 9BA

MYROBALAN THERAPEUTICS

synthetic small molecule pharmaceutical preparations for the treatment of neurodegenerative diseases, demyelination diseases, schizophrenia spectrum d Read More

Classification Information


Class [5]
Pharmaceutical Products


Synthetic small molecule pharmaceutical preparations for the treatment of neurodegenerative diseases, demyelination diseases, schizophrenia spectrum disorders, neuropathic pain, neuroinflammation diseases, neuroexcitation disorders, immunological disorders and cancers.

Class [42]
Computer & Software Services & Scientific Services


Research and development of synthetic small molecule pharmaceutical preparations.

Mark Details


Serial Number

UK00003767421

Mark Type

Word

Kind of mark

Individual